Potential role of mefloquine (antimalarial drug) and methanol extract of Chenopodium ambrosioides and Sesbania sesban in mice infected with Schistosoma mansoni

Theodor Bilharz Research Institute

Bibliographic Information

Authors: El-Emam M.A.-W.; Mahmoud S.S.; Bayaumy F.E.L.-Z.A.

Journal: Asian Pacific Journal of Tropical Disease

Publisher: Elsevier B.V.

Publication Date: August 2015

Volume / Issue: Volume 5 / Issue 8

Pages: 608–613

ISSN: 22221808

DOI: 10.1016/S2222-1808(15)60898-2

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Gold Open Access


Authors and Affiliations

El-Emam M.A.-W., Medical Malacology and Parasitology Departments, Theodor Bilharz Research Institute, Imbaba, Giza, Egypt; Mahmoud S.S., Medical Malacology and Parasitology Departments, Theodor Bilharz Research Institute, Imbaba, Giza, Egypt; Bayaumy F.E.L.-Z.A., Zoology Department, Faculty of Women for Arts, Science and Education, Ain Shams University, Cairo, Egypt


Abstract

Objective: To elucidate the efficacy of mefloquine and methanol extract of the plants Chenopodium ambrosioides (C. ambrosioides) and Sesbania sesban (S. sesban) as a combined therapy for the treatment of Schistosoma mansoni (S. mansoni) infected mice, and study the parasitological, biochemical and histological parameters of treated mice. Methods: Two groups of male Swiss Albino mice were infected with S. mansoni cercariae. The first group untreated served as control. The second group was orally treated with a single dose (200 mg/kg) of mefloquine 3 weeks post infection, then subsequently divided into 2 sub-groups; the first orally retreated with the plant extracts 1 000 mg/kg of S. sesban followed by 1 250 mg/kg of C. ambrosioides with an 1 h interval, for 2 successive days. The second sub-group was re-treated with the same (dose and method) plant extracts after 7 weeks post infection. Results: The results showed that S. mansoni infected mice treated with mefloquine and the plants' extracts 3 weeks post infection significantly (P < 0.01) reduced the worm burden/mouse by 95.5% and the few worms recovered from sacrificed mice in this treatment failed to lay ova. Moreover, no worms were recovered from infected mice treated with mefloquine (3 weeks post infection) and re-treated by the plant's extracts at 7 weeks post infection. Also, treatment of infected mice with mefloquine followed by the plants' extracts either at 3 or 7 weeks post infection ameliorated the activities of the serum enzymes alanine aminotransferase, aspartate aminotransferase, alkline phosphatase and acid phosphatase as well as the hepatic granulomatous lesions compared to infected untreated group. Conclusions: It is concluded that successive treatment of S. mansoni infected mice with mefloquine and methanol extract of the plants C. ambrosioides and S. sesban could be a promising device in the strategy of schistosomiasis control. © 2015 by the Asian Pacific Journal of Tropical Disease.


Keywords

Albino mice; Mefloquine; Plant's extract; Schistosoma mansoni; acid phosphatase; alanine aminotransferase; alkaline phosphatase; antischistosomal agent; aspartate aminotransferase; Chenopodium ambrosioides extract; methanol; plant extract; Sesbania sesban extract; unclassified drug; acid phosphatase blood level; alanine aminotransferase blood level; alkaline phosphatase blood level; animal experiment; animal model; animal tissue; Article; aspartate aminotransferase blood level; cercaria; controlled study; drug efficacy; enzyme activity; granulomatous inflammation; histopathology; infection control; male; mouse; nonhuman; outcome assessment; parasite examination; parasite load; priority journal; schistosomiasis mansoni; Sesbania; Sesbania sesban; single drug dose; Swiss Webster mouse; treatment duration


Citation Information

Scopus Citations: 5


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects